Quantitative Magnetization Transfer Imaging of the Breast at 3.0 T: Reproducibility in Healthy Volunteers
Author(s) -
Lori R. Arlinghaus,
Richard Dortch,
Jennifer G. Whisenant,
Hakmook Kang,
Richard G. Abramson,
Thomas E. Yankeelov
Publication year - 2016
Publication title -
tomography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.074
H-Index - 9
eISSN - 2379-139X
pISSN - 2379-1381
DOI - 10.18383/j.tom.2016.00142
Subject(s) - reproducibility , repeatability , breast cancer , volunteer , magnetization transfer , medicine , magnetic resonance imaging , nuclear medicine , confidence interval , breast tissue , breast imaging , radiology , nuclear magnetic resonance , biomedical engineering , cancer , chemistry , mammography , biology , physics , chromatography , agronomy
Quantitative magnetization transfer magnetic resonance imaging provides a means for indirectly detecting changes in the macromolecular content of tissue noninvasively. A potential application is the diagnosis and assessment of treatment response in breast cancer; however, before quantitative magnetization transfer imaging can be reliably used in such settings, the technique's reproducibility in healthy breast tissue must be established. Thus, this study aims to establish the reproducibility of the measurement of the macromolecular-to-free water proton pool size ratio (PSR) in healthy fibroglandular (FG) breast tissue. Thirteen women with no history of breast disease were scanned twice within a single scanning session, with repositioning between scans. Eleven women had appreciable FG tissue for test-retest measurements. Mean PSR values for the FG tissue ranged from 9.5% to 16.7%. The absolute value of the difference between 2 mean PSR measurements for each volunteer ranged from 0.1% to 2.1%. The 95% confidence interval for the mean difference was ±0.75%, and the repeatability value was 2.39%. These results indicate that the expected measurement variability would be ±0.75% for a cohort of a similar size and would be ±2.39% for an individual, suggesting that future studies of change in PSR in patients with breast cancer are feasible.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom